AG 1284Alternative Names: AG 1157; AG 1345
Latest Information Update: 01 May 1995
At a glance
- Originator Agouron Pharmaceuticals
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 01 May 1995 Discontinued-Preclinical for HIV-1 infections in USA (PO)